248 related articles for article (PubMed ID: 31502646)
41. Betaine supplementation causes increase in carnitine metabolites in the muscle and liver of mice fed a high-fat diet as studied by nontargeted LC-MS metabolomics approach.
Pekkinen J; Olli K; Huotari A; Tiihonen K; Keski-Rahkonen P; Lehtonen M; Auriola S; Kolehmainen M; Mykkänen H; Poutanen K; Hanhineva K
Mol Nutr Food Res; 2013 Nov; 57(11):1959-68. PubMed ID: 23868375
[TBL] [Abstract][Full Text] [Related]
42. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
Wang N; Zhu F; Chen L; Chen K
Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
[TBL] [Abstract][Full Text] [Related]
43. Metabolomics reveals the impact of Type 2 diabetes on local muscle and vascular responses to ischemic stress.
Beckman JA; Hu JR; Huang S; Farber-Eger E; Wells QS; Wang TJ; Gerszten RE; Ferguson JF
Clin Sci (Lond); 2020 Sep; 134(17):2369-2379. PubMed ID: 32880388
[TBL] [Abstract][Full Text] [Related]
44. Serum metabolite profile associated with incident type 2 diabetes in Koreans: findings from the Korean Genome and Epidemiology Study.
Yang SJ; Kwak SY; Jo G; Song TJ; Shin MJ
Sci Rep; 2018 May; 8(1):8207. PubMed ID: 29844477
[TBL] [Abstract][Full Text] [Related]
45. Triangulating evidence from longitudinal and Mendelian randomization studies of metabolomic biomarkers for type 2 diabetes.
Porcu E; Gilardi F; Darrous L; Yengo L; Bararpour N; Gasser M; Marques-Vidal P; Froguel P; Waeber G; Thomas A; Kutalik Z
Sci Rep; 2021 Mar; 11(1):6197. PubMed ID: 33737653
[TBL] [Abstract][Full Text] [Related]
46. Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study.
Guasch-Ferré M; Hu FB; Ruiz-Canela M; Bulló M; Toledo E; Wang DD; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Lapetra J; Fitó M; Arós F; Serra-Majem L; Ros E; Dennis C; Liang L; Clish CB; Martínez-González MA; Salas-Salvadó J
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080862
[TBL] [Abstract][Full Text] [Related]
47. Exposure to disinfection byproducts and risk of type 2 diabetes: a nested case-control study in the HUNT and Lifelines cohorts.
Gängler S; Waldenberger M; Artati A; Adamski J; van Bolhuis JN; Sørgjerd EP; van Vliet-Ostaptchouk J; Makris KC
Metabolomics; 2019 Apr; 15(4):60. PubMed ID: 30963292
[TBL] [Abstract][Full Text] [Related]
48. Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort.
Titan SM; Venturini G; Padilha K; Goulart AC; Lotufo PA; Bensenor IJ; Krieger JE; Thadhani RI; Rhee EP; Pereira AC
PLoS One; 2019; 14(3):e0213764. PubMed ID: 30883578
[TBL] [Abstract][Full Text] [Related]
49. Importance of sulfur-containing metabolites in discriminating fecal extracts between normal and type-2 diabetic mice.
Walker A; Lucio M; Pfitzner B; Scheerer MF; Neschen S; de Angelis MH; Hartmann A; Schmitt-Kopplin P
J Proteome Res; 2014 Oct; 13(10):4220-31. PubMed ID: 24991707
[TBL] [Abstract][Full Text] [Related]
50. Oxidized glycerophosphatidylcholines in diabetes through non-targeted metabolomics: Their annotation and biological meaning.
Godzien J; Kalaska B; Adamska-Patruno E; Siroka J; Ciborowski M; Kretowski A; Barbas C
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():62-70. PubMed ID: 31071580
[TBL] [Abstract][Full Text] [Related]
51. miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease.
Gallo W; Esguerra JLS; Eliasson L; Melander O
PLoS One; 2018; 13(11):e0206974. PubMed ID: 30408096
[TBL] [Abstract][Full Text] [Related]
52. Simultaneous quantification of cardiovascular disease related metabolic risk factors using liquid chromatography tandem mass spectrometry in human serum.
Wang M; Yang R; Dong J; Zhang T; Wang S; Zhou W; Li H; Zhao H; Zhang L; Wang S; Zhang C; Chen W
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():144-51. PubMed ID: 26735710
[TBL] [Abstract][Full Text] [Related]
53. A Preliminary Study Showing the Impact of Genetic and Dietary Factors on GC-MS-Based Plasma Metabolome of Patients with and without
Mojsak P; Miniewska K; Godlewski A; Adamska-Patruno E; Samczuk P; Rey-Stolle F; Bauer W; Barbas C; Kretowski A; Ciborowski M
Curr Issues Mol Biol; 2021 Jun; 43(2):513-528. PubMed ID: 34209638
[TBL] [Abstract][Full Text] [Related]
54. Inadequate hepcidin serum concentrations predict incident type 2 diabetes mellitus.
Pechlaner R; Weiss G; Bansal S; Mayr M; Santer P; Pallhuber B; Notdurfter M; Bonora E; Willeit J; Kiechl S
Diabetes Metab Res Rev; 2016 Feb; 32(2):187-92. PubMed ID: 26378394
[TBL] [Abstract][Full Text] [Related]
55. Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts.
Ahola-Olli AV; Mustelin L; Kalimeri M; Kettunen J; Jokelainen J; Auvinen J; Puukka K; Havulinna AS; Lehtimäki T; Kähönen M; Juonala M; Keinänen-Kiukaanniemi S; Salomaa V; Perola M; Järvelin MR; Ala-Korpela M; Raitakari O; Würtz P
Diabetologia; 2019 Dec; 62(12):2298-2309. PubMed ID: 31584131
[TBL] [Abstract][Full Text] [Related]
56. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.
Razquin C; Ruiz-Canela M; Clish CB; Li J; Toledo E; Dennis C; Liang L; Salas-Huetos A; Pierce KA; Guasch-Ferré M; Corella D; Ros E; Estruch R; Gómez-Gracia E; Fitó M; Lapetra J; Romaguera D; Alonso-Gómez A; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA
Cardiovasc Diabetol; 2019 Nov; 18(1):151. PubMed ID: 31722714
[TBL] [Abstract][Full Text] [Related]
57. Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans.
Chen ZZ; Pacheco JA; Gao Y; Deng S; Peterson B; Shi X; Zheng S; Tahir UA; Katz DH; Cruz DE; Ngo D; Benson MD; Robbins JM; Guo X; Del Rocio Sevilla Gonzalez M; Manning A; Correa A; Meigs JB; Taylor KD; Rich SS; Goodarzi MO; Rotter JI; Wilson JG; Clish CB; Gerszten RE
Diabetes; 2022 Nov; 71(11):2426-2437. PubMed ID: 35998269
[TBL] [Abstract][Full Text] [Related]
58. Integrated use of LC/MS/MS and LC/Q-TOF/MS targeted metabolomics with automated label-free microscopy for quantification of purine metabolites in cultured mammalian cells.
Nybo SE; Lamberts JT
Purinergic Signal; 2019 Mar; 15(1):17-25. PubMed ID: 30604179
[TBL] [Abstract][Full Text] [Related]
59. Metabonomic study of biochemical changes in urinary of type 2 diabetes mellitus patients after the treatment of sulfonylurea antidiabetic drugs based on ultra-performance liquid chromatography/mass spectrometry.
Huo T; Xiong Z; Lu X; Cai S
Biomed Chromatogr; 2015 Jan; 29(1):115-22. PubMed ID: 24890121
[TBL] [Abstract][Full Text] [Related]
60. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.
Zhu C; Liang QL; Hu P; Wang YM; Luo GA
Talanta; 2011 Sep; 85(4):1711-20. PubMed ID: 21872008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
